Kemantane

CAS No. 20098-14-0

Kemantane( Idramantone )

Catalog No. M13136 CAS No. 20098-14-0

Idramantone is an immune agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
100MG Get Quote In Stock
200MG 29 In Stock
500MG 45 In Stock
1G 65 In Stock

Biological Information

  • Product Name
    Kemantane
  • Note
    Research use only, not for human use.
  • Brief Description
    Idramantone is an immune agonist.
  • Description
    Idramantone is an immune agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Idramantone
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    20098-14-0
  • Formula Weight
    166.22
  • Molecular Formula
    C10H14O2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    O=C1C2CC3CC(C2)(O)CC1C3
  • Chemical Name
    5-Hydroxy-2-adamantanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mirzoian NR, et al. Eksp Klin Farmakol. 2013; 76(6): 7-10.
molnova catalog
related products
  • Corey Lactone Diol

    Corey Lactone Diol is a pharmaceutical intermediate.

  • Tibesaikosaponin V

    Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.

  • (D-Arg1,D-Pro2,D-Phe...

    (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P is a selective NK1 receptor antagonist.